https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Somatic copy number amplification and hyperactivating somatic mutations of EZH2 correlate with DNA methylation and drive epigenetic silencing of genes involved in tumor suppression and immune responses in melanoma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29412 Wed 11 Apr 2018 09:50:06 AEST ]]> The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20163 Sat 24 Mar 2018 07:51:41 AEDT ]]> EZH2 as a mediator of treatment resistance in melanoma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29370 Sat 24 Mar 2018 07:34:17 AEDT ]]> Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48634 3.5-fold after steroid and ATG treatment. This case illustrates the need to consider this form of steroid resistance in patients failing treatment with corticosteroids. It also highlights the need for both better identification of patients at risk and the development of treatments that involve more specific immune suppression.]]> Mon 03 Apr 2023 10:14:28 AEST ]]>